CY2038B1 - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number
CY2038B1
CY2038B1 CY9802038A CY9802038A CY2038B1 CY 2038 B1 CY2038 B1 CY 2038B1 CY 9802038 A CY9802038 A CY 9802038A CY 9802038 A CY9802038 A CY 9802038A CY 2038 B1 CY2038 B1 CY 2038B1
Authority
CY
Cyprus
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Application number
CY9802038A
Other languages
English (en)
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of CY2038B1 publication Critical patent/CY2038B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
CY9802038A 1992-04-16 1998-04-30 Indole derivatives CY2038B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208492A GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
CY2038B1 true CY2038B1 (en) 1998-04-30

Family

ID=10714220

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9802038A CY2038B1 (en) 1992-04-16 1998-04-30 Indole derivatives

Country Status (41)

Country Link
US (4) US5374648A (ro)
EP (1) EP0568136A1 (ro)
JP (2) JPH07505407A (ro)
KR (1) KR100264114B1 (ro)
CN (1) CN1042331C (ro)
AP (1) AP480A (ro)
AT (1) AT403917B (ro)
AU (1) AU666927B2 (ro)
BE (1) BE1006343A5 (ro)
BG (1) BG62136B1 (ro)
BR (1) BR1100323A (ro)
CA (3) CA2094073A1 (ro)
CH (1) CH685630A5 (ro)
CY (1) CY2038B1 (ro)
CZ (1) CZ285799B6 (ro)
DK (1) DK169890B1 (ro)
ES (1) ES2105924B1 (ro)
FI (1) FI106198B (ro)
FR (1) FR2690919B1 (ro)
GB (2) GB9208492D0 (ro)
GE (1) GEP19991704B (ro)
GR (1) GR1001619B (ro)
HK (1) HK95797A (ro)
HU (2) HU217964B (ro)
IL (1) IL105412A (ro)
IS (1) IS3994A (ro)
IT (1) IT1265325B1 (ro)
LU (1) LU88248A1 (ro)
MX (1) MX9302195A (ro)
MY (1) MY112232A (ro)
NO (1) NO301879B1 (ro)
NZ (1) NZ247413A (ro)
OA (1) OA10103A (ro)
PL (1) PL176451B1 (ro)
RO (1) RO113242B1 (ro)
RU (1) RU2129544C1 (ro)
SE (1) SE504336C2 (ro)
SK (1) SK281941B6 (ro)
TW (1) TW224457B (ro)
WO (1) WO1993021153A1 (ro)
ZA (1) ZA932642B (ro)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
CA2161768C (en) * 1993-05-27 1998-08-18 Francesco G. Salituro 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
TW280819B (ro) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
GB9504361D0 (en) * 1995-03-04 1995-04-26 Glaxo Spa Heterocyclic compounds
AU4416197A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Positive ampa receptor modulation to enhance brain neurotrophic factor expression
BR9712144A (pt) * 1996-09-30 1999-08-31 Hoechst Marion Roussel Inc Novos antagonistas de nmda (d- aspartato de n-metila).
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
PT1421939E (pt) * 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
JP2005518371A (ja) * 2001-12-10 2005-06-23 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療に於けるこれらの使用
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
JP2006526612A (ja) * 2003-06-05 2006-11-24 ファイザー・プロダクツ・インク ベータ−ラクタマーゼ阻害剤・プロドラッグ
DE602004028150D1 (de) * 2003-11-26 2010-08-26 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
KR20060128976A (ko) * 2003-12-29 2006-12-14 세프라코 아이엔시. 피롤 및 피라졸 디에이에이오 억제제
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
EP1904066B1 (en) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
WO2007081542A2 (en) * 2006-01-06 2007-07-19 Sepracor Inc. Tetralone-based monoamine reuptake inhibitors
JP5432526B2 (ja) 2006-01-06 2014-03-05 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害剤としてのシクロアルキルアミン
EP2013835B1 (en) 2006-03-31 2015-11-04 Sunovion Pharmaceuticals Inc. Preparation of chiral amides and amines
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (en) 2006-12-20 2008-07-09 sanofi-aventis Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
AU2008206039A1 (en) * 2007-01-18 2008-07-24 Sepracor Inc. Inhibitors of D-amino acid oxidase
CN103936605B (zh) 2007-05-31 2017-09-01 赛诺维信制药公司 苯基取代的环烷胺作为一元胺再摄取抑制剂
WO2009151498A2 (en) * 2008-03-28 2009-12-17 Forest Laboratories Holdings Limited Memantine formulations
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
CA2755118A1 (en) 2009-03-10 2010-09-16 Santen Pharmaceutical Co., Ltd. Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CN112773798B (zh) 2014-04-30 2024-03-29 宇凤·简·曾 作为d-氨基酸氧化酶抑制剂的已知化合物的用途
MX2019002726A (es) 2016-09-14 2019-09-23 Jane Tseng Yufeng Novedosos derivados sustituidos como inhibidores de la d-aminoacido oxidasa (daao).
AU2018284335A1 (en) 2017-06-12 2020-01-30 Glytech Llc. Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists
CN112707874A (zh) * 2020-12-29 2021-04-27 广东中科药物研究有限公司 一种抗病毒化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010971A (en) * 1960-08-04 1961-11-28 Smith Kline French Lab Cyclopropylamine derivatives and processes for their preparation
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
EP0539503B1 (en) * 1990-07-16 1996-04-03 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity

Also Published As

Publication number Publication date
CA2094073A1 (en) 1993-10-17
KR100264114B1 (ko) 2000-11-01
BE1006343A5 (fr) 1994-07-26
CH685630A5 (fr) 1995-08-31
DK169890B1 (da) 1995-03-27
MY112232A (en) 2001-05-31
GB9208492D0 (en) 1992-06-03
PL176451B1 (pl) 1999-05-31
CZ254394A3 (en) 1995-07-12
NO943913L (no) 1994-12-14
AU666927B2 (en) 1996-02-29
IT1265325B1 (it) 1996-10-31
SK281941B6 (sk) 2001-09-11
US5374649A (en) 1994-12-20
RO113242B1 (ro) 1998-05-29
JPH07505407A (ja) 1995-06-15
CZ285799B6 (cs) 1999-11-17
US5510367A (en) 1996-04-23
FR2690919A1 (fr) 1993-11-12
HK95797A (en) 1997-08-08
NO943913D0 (no) 1994-10-14
GB2266091B (en) 1995-08-09
NZ247413A (en) 1995-12-21
ES2105924B1 (es) 1998-07-01
GB9307808D0 (en) 1993-06-02
SE504336C2 (sv) 1997-01-13
IL105412A (en) 1998-02-22
OA10103A (en) 1996-12-18
BR1100323A (pt) 2000-06-27
DK43193A (da) 1993-10-17
EP0568136A1 (en) 1993-11-03
FI944800A0 (fi) 1994-10-12
HU217964B (hu) 2000-05-28
SK124194A3 (en) 1995-05-10
ES2105924A1 (es) 1997-10-16
BG62136B1 (bg) 1999-03-31
IS3994A (is) 1993-10-17
SE9301241D0 (sv) 1993-04-15
ZA932642B (en) 1994-01-10
CA2094076A1 (en) 1993-10-17
RU2129544C1 (ru) 1999-04-27
NO301879B1 (no) 1997-12-22
CN1085212A (zh) 1994-04-13
CN1042331C (zh) 1999-03-03
FR2690919B1 (fr) 1995-05-05
RU94045915A (ru) 1996-09-10
ATA75293A (de) 1997-11-15
JPH0649027A (ja) 1994-02-22
HUT70526A (en) 1995-10-30
IL105412A0 (en) 1993-08-18
TW224457B (ro) 1994-06-01
CA2094075A1 (en) 1993-10-17
HU9402975D0 (en) 1995-02-28
ITRM930236A0 (it) 1993-04-15
BG99111A (bg) 1995-05-31
DK43193D0 (da) 1993-04-15
HU211826A9 (en) 1995-12-28
ITRM930236A1 (it) 1994-10-15
AP9300524A0 (en) 1993-04-30
AU3692393A (en) 1993-10-21
US5373018A (en) 1994-12-13
GEP19991704B (en) 1999-08-05
FI944800A (fi) 1994-10-12
US5374648A (en) 1994-12-20
LU88248A1 (fr) 1994-03-01
WO1993021153A1 (en) 1993-10-28
FI106198B (fi) 2000-12-15
GB2266091A (en) 1993-10-20
MX9302195A (es) 1994-03-31
SE9301241L (sv) 1993-10-17
AT403917B (de) 1998-06-25
GR1001619B (el) 1994-07-29
AP480A (en) 1996-03-22

Similar Documents

Publication Publication Date Title
GB2266091B (en) Indole derivatives
GB2251614B (en) Indole derivatives
IL105206A0 (en) Indole derivatives
ZA942383B (en) New indole derivatives
IL105312A0 (en) Indoles
ZA941483B (en) Indole derivatives
AP9400685A0 (en) Indole derivatives
ZA947210B (en) Indole derivatives
GB9326332D0 (en) Indole derivatives
HU9201550D0 (en) Indole derivatives
IL109376A0 (en) Indole derivatives
GB9116732D0 (en) Indole derivatives
GB9204024D0 (en) Indole derivatives
GB9302577D0 (en) Indole derivatives
GB9206810D0 (en) Indole derivatives
GB9206787D0 (en) Indole derivatives
IL121326A0 (en) Indole derivatives
GB9215961D0 (en) Indole derivatives
GB9206056D0 (en) Indole derivatives
GB9218595D0 (en) Indole derivatives
GB9206809D0 (en) Indole derivatives
GB9206794D0 (en) Indole derivatives
GB9307080D0 (en) Indole derivatives
GB9310092D0 (en) Indole derivatives
GB9309148D0 (en) Indole derivatives